Current therapeutic strategies in non-alcoholic fatty liver disease.

  title={Current therapeutic strategies in non-alcoholic fatty liver disease.},
  author={Joanna K. Dowman and Matthew James Armstrong and J W Tomlinson and Philip N Newsome},
  journal={Diabetes, obesity & metabolism},
  volume={13 8},
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease ranging from simple steatosis through steatohepatitis (NASH) to increasing fibrosis and eventual cirrhosis. NAFLD is the hepatic manifestation of the metabolic syndrome and has now become the most common cause of liver disease in Western countries, with the more advanced stages of disease being associated with an increased risk of liver-related morbidity and mortality. The optimal management of patients with NAFLD… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 12 times over the past 90 days. VIEW TWEETS
33 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 33 extracted citations

Similar Papers

Loading similar papers…